Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 220 of 1,261
  1. US 11529427

    Gene editing for hemophilia A with improved factor VIII expression

    CRISPR THERAPEUTICS AG · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  2. US 11530194

    Amide compounds and method for making and using

    Rigel Pharmaceuticals, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  3. US 11529390

    PCSK9 inhibitory polypolypeptides and methods of use

    INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  4. US 11530236

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  5. US 11529395

    Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

    Takeda Pharmaceutical Company Limited · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  6. US 11528924

    Alcoholic beverage substitutes

    CLEARMIND MEDICINE INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  7. US 11530421

    Self-inactivating endonuclease-encoding nucleic acids and methods of using the same

    The Regents of the University of California · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  8. US 11530259

    Therapies and methods to treat TLR2-mediated diseases and disorders

    The Regents of the University of California · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  9. US 11530244

    Cyclic polypeptides for PCSK9 inhibition

    RA PHARMACEUTICALS, INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  10. US 11529363

    Methods of treating cancer in pediatric patients

    Takeda Pharmaceutical Company Limited · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  11. US 11530432

    Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates

    Northwestern University · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  12. US 11529375

    Compositions and methods for treating diverticulitis and related disorders

    Finch Therapeutics Holdings LLC · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  13. US 11529360

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  14. US 11529373

    Method for enhancing expression of insulin like growth factor 1 receptor in mesenchymal stem cell, method for obtaining mesenchymal stem cell, and method for treating brain tissue damage

    China Medical University · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  15. US 11530229

    Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof

    NURIX THERAPEUTICS, INC. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  16. US 11529340

    Combination for treating pain

    Regents of the University of Minnesota · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  17. US 11529312

    Francisella lipids as broad anti-inflammatory therapeutics and associated methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  18. US 11530239

    Methods and compositions for treating diseases and conditions associated with gonadotropin releasing hormone receptor

    The Board of Regents of the University of Oklahoma · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  19. US 11529298

    Cosmetic composition and its use, dermocosmetic formulation

    LUXBIOTECH FARMACÉUTICA LTDA · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  20. US 11530424

    Efficient CRISPR/HDR-mediated knock-in system and method of use

    United States Department of Veteran Affairs · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  21. US 11529314

    Lipid-based nanoparticles for encapsulation and sustained release of therapeutic agents

    The Board of Regents of the University of Texas System · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  22. US 11529337

    Method of treating pain

    Vertex Pharmaceuticals Incorporated · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  23. US 11529417

    Wound healing through sirt1 overexpression

    Northwestern University · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  24. US 11530196

    Pyrimidine compound acting on EGFR and ERBB2

    CHINA RESOURCES PHARMACEUTICAL HOLDINGS COMPANY LIMITED · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.